CA2244887C - Photoprotective compositions - Google Patents

Photoprotective compositions Download PDF

Info

Publication number
CA2244887C
CA2244887C CA002244887A CA2244887A CA2244887C CA 2244887 C CA2244887 C CA 2244887C CA 002244887 A CA002244887 A CA 002244887A CA 2244887 A CA2244887 A CA 2244887A CA 2244887 C CA2244887 C CA 2244887C
Authority
CA
Canada
Prior art keywords
group
mixtures
polymers
acid
composition according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CA002244887A
Other languages
French (fr)
Other versions
CA2244887A1 (en
Inventor
Paul Robert Tanner
Julie Ann Wagner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Procter and Gamble Co
Original Assignee
Procter and Gamble Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter and Gamble Co filed Critical Procter and Gamble Co
Publication of CA2244887A1 publication Critical patent/CA2244887A1/en
Application granted granted Critical
Publication of CA2244887C publication Critical patent/CA2244887C/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/27Zinc; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/29Titanium; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • A61K8/342Alcohols having more than seven atoms in an unbroken chain
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/35Ketones, e.g. benzophenone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36Carboxylic acids; Salts or anhydrides thereof
    • A61K8/365Hydroxycarboxylic acids; Ketocarboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37Esters of carboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/39Derivatives containing from 2 to 10 oxyalkylene groups
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/41Amines
    • A61K8/411Aromatic amines, i.e. where the amino group is directly linked to the aromatic nucleus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • A61K8/466Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur containing sulfonic acid derivatives; Salts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67Vitamins
    • A61K8/673Vitamin B group
    • A61K8/675Vitamin B3 or vitamin B3 active, e.g. nicotinamide, nicotinic acid, nicotinyl aldehyde
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67Vitamins
    • A61K8/676Ascorbic acid, i.e. vitamin C
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67Vitamins
    • A61K8/678Tocopherol, i.e. vitamin E
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73Polysaccharides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/8141Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
    • A61K8/8147Homopolymers or copolymers of acids; Metal or ammonium salts thereof, e.g. crotonic acid, (meth)acrylic acid; Compositions of derivatives of such polymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/8141Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
    • A61K8/8152Homopolymers or copolymers of esters, e.g. (meth)acrylic acid esters; Compositions of derivatives of such polymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/8141Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
    • A61K8/8158Homopolymers or copolymers of amides or imides, e.g. (meth) acrylamide; Compositions of derivatives of such polymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/8164Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a carboxyl radical, and containing at least one other carboxyl radical in the molecule, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers, e.g. poly (methyl vinyl ether-co-maleic anhydride)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/817Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a single or double bond to nitrogen or by a heterocyclic ring containing nitrogen; Compositions or derivatives of such polymers, e.g. vinylimidazol, vinylcaprolactame, allylamines (Polyquaternium 6)
    • A61K8/8176Homopolymers of N-vinyl-pyrrolidones. Compositions of derivatives of such polymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/98Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
    • A61K8/981Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of mammals or bird
    • A61K8/982Reproductive organs; Embryos, Eggs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/16Emollients or protectives, e.g. against radiation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/02Preparations for care of the skin for chemically bleaching or whitening the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/59Mixtures
    • A61K2800/596Mixtures of surface active compounds

Abstract

The present invention relates to leave on, skin care compositions, comprising:
(a) from about 0.1 % to about 30 % of a sunscreen active, (b) from about 0.5 %
to about 20 % of a hydrophobic, structuring agent, (c) from about 0.2 % to about 10 % of a hydrophilic surfactant, (d) from about 0.1 % to about 5 % of a thickening agent, and (e) water. These compositions are useful for providing protection to human skin from the harmful effects of ultraviolet radiation.

Description

I: . ~~ 'r~ E , ~I I ;I ,~

' WO 97/28785 PCTlUS97/01170 PHOTOPROTECTIVE COMPOSITIONS
TECHNICI~L FIELD
The present invention relates to compositions which are useful for providing protection to the skin of humans from the harmful effects of ultraviolet radiation. fn particular it relates to stable, cosmetic, aqueous-containing compositions having gel networks, liquid crystalline phases, or both.
These compositions also contain a thickening agent. Without being limited by theory, it is believed that the aqueous phase of these compositions contain relatively-low levels of free water. 1n other words, the water is believed to be bound as part of the ge! network or liquid crystals. 'These compositions are found to be especially useful for delivering sunscreen actives to the skin.
The damaging effects of sunlight on skin are well documented. Contrary to what most people believe, it is not necessary that one sunbathe to suffer the ill-effects of excessive W
exposure. In fact, significant damage can be done just by routine day to day activities in sunlight.
The major short term hazard of proloztged exposure to sunlight.is erytttema, i.e. sunburn. In addition to the short term hazard are long term hazards such as malignant changes in the skin surface.
Numerous epidcminologic studies demonstrate a strong relationship between sunlight exposure and human skin cancer. Another long term ha:ard of ultraviolet radiation is premature aging of the skin.
This condition is characterized by wrinkling and pigment changes of the skin, along with other physical changes such as cracking, telangiectasis, solar detmatoses, ecchymoses, , and loss of elasticity. The adverse effects associated with exposure to W radiation are more fully discussed in DeSimone, "Sunscreen and Suntan Products," Handbook of Nonprescription Drags, 7th Ed., Chapter 26, pp. 499-511 (American Phamtaceuticat Association, Washington, D.C.; 1982);
Grove and Forties, "A Method for Evaluating the Photoprotection Action of Sunscreen Agents Against UV-A
Radiation," Irrternatioaal Journal of Cosmetic Science, 4, pp. 15-24 ( 1982);
and U.S. Patent No.
4,387,089, DePolo, issued lime 7, 1983.
Hence, although the immediate effxts of ultraviolet radiation may be cosmetically and socially gratifying, the long term hazards are cumulative and potentially serious.
The fact that these effects are taken seriously by the general public is suggested by considering the sun prouction product market. This marks has grown considerably is recent years and many new praiucts are introduced each year. What used to be looked upon as a seasonal business is no longer seen as such. Sunscreen agents are now inchrded in a diversity of personal care products, particularly cosmic type products which are worn on a-daily basis.
Sunscreen formulas ate generally based on oil-in-water and water-in-oil emulsion systems.
However, inany conventional systems suffer from disadvantages such as inefficient W protection, chemical and physical instability, and unattractive aesthetic properties when applied to the skin. It WO 97/28785 PCT/US97lOI170 has surprisingly been found that the photoprotective compositions of the present invention overcome these disadvantages. These compositions comprise a sunscreen active, a stable, hydrophobic, structuring agent, a hydrophilic surfactant, a thickening agent, and water.
Without being limited by theory, it is believed that these compositions contain gel network structures, liquid crystal structures, , or both. It is believed that these gel networks and liquid crystals tend to bind the available water in the composition, thereby rendering the water less available for contributing to the instability and , decomposition of the active ingredients. It is also found that these compositions are well-suited for formulating with highly polar materials, e.g., inorganic sunscreen agents such as titanium dioxide, zinc oxide, and iron oxide, which are often used to enhance or boost the UV
protection effects of organic type sunscreen agents. Additionally, it is found that these compositions have good aesthetic, i.e. skin feel properties.
Therefore, it is an object of the present invention to provide novel compositions for providing protection from the harmful effects of UV radiation to the skin.
It is a fitrther object of the present invention to provide photoprotective compositions comprising water, and having gel networks, liquid crystals or both.
It is a further object of the present invention to provide photoprotective compositions which are both chemically and physically stable.
It is a further objective of the present invention to provide photoprotective compositions which have an aesthetically appealing feel when applied to the skin.
These and other objects will become readily apparent from the detailed description which follows.
SUMMARY OF THE INVENTION
The present invention relates to photoprotective compositions that are useful for protecting human skin from the harmful effects of UV radiation comprising:
(a) from about 0.1 % to about 30% of a sunscreen active;
(b} from about 0.5% to about 20% of a hydrophobic, structuring agent selected from the group consisting of saturated C 16 to C30 fatty alcohols, saturated C 16 to C30 fatty alcohols containing from about 1 to about 5 moles of ethylene oxide, saturated C 16 to C30 diols, saturated C16 to C30 monoglycerol ethers, saturated C16 to C30 hydroxy fatty acids, and mixtures thereof, having a melting point of at least about 40°C;
(c) from about 0.2 % to about 10% of a hydrophilic surfactant selected from the group consisting of nonionic surfactants, anionic surfactants, cationic surfactants, zwitterionic surfactants, amphoteric surfactants, and mixtures thereof; ' (d) from about 0.1% to about 5% of a thickening agent selected from the group consisting of carboxylic acid polymers, crosslinked polyacrylate polymers, poiyacrylamide polymers, polysaccharides, gums, crosslinked vineyl etherimaleic anhydride copolymers, crosslinked poly(N-vinytpyrrolidones), and mixtures thereof, and p, ,~ . ,I'~ I 41 ~ i ' WO 97/28?85 'PCT/US97/01170 .
(e) from about 25% to about 99.1% water.
In further embodiments, the present invention also relates to methods for providing protection to human skin from the harmful effects of UV radiation.
All percentages and ratios used herein are by weight of the total composition.
All measurements made are at 25oC, unless otherwise designated. A(1 weight percentages, unless otherwise indicated, are on an actives weight basis. The invention hereof can comprise, consist of, or consist essentially of, the essential as well as optional ingredients and components described herein.
DETAILED DESCRIP'T~ON OF THE INVENTION
The compositions of the present invention are useful for providing protection to human skin from the harmful effects of ultraviolet radiation. These compositions are in the form of oil-in-water emulsions whereby the oil phase and the water phase can contain, in addition to the essential components described herein, a variety of ingredients known in the art. These compositions are in the form of topical, leave-on compositions. The compositions herein are useful for topical application to the skin.
The term "topical application," as used herein, means to apply or spread the compositions to the surface of the skin.
Tlie term "phatmaceuticslly acceptable," as used herein, means that the emnpositions or components thereof so described are suitable for use in contact with human skin without undue toxicity, incompstibiiity, instability, allergic response, and the tike.
The compositions of the present invention have complex rbeologicsl characteristics. These compositions have physical properties characteristic of oil-in-water emulsions, liquid crystals, and crystalline gel networks. Without being limited by theory, it is believed that these compositions have low levels of free water, such that most of the water is bound up with liquid crystals or gel networks.
It is found that these compositions are useful as vehicles for compositions which arc labile in aqueous solution or dispersion. It is also found that these compositions are useful for fotmufating with actives which are highly polar, such as Physical sunscreen agents such as titanium dioxide, zinc oxide, iron oxide, ~d the like.
'Ihe nature of liquid cry~ais, the formation of lic~id crystals, the pcopetaes and advantages of liqerid zrys~is, acrd get networks are described further in G. Dahrns, "Properties of O/W Emulsions with Anisotropic Lameilar Phases," 101 Cosmetics 8t Toiletries 113~115, (1986); P. Loll, "Liquid Crystals in Cosmetic Emulsions," S"I ~rfg,.~H..~ats Publication 1tP94-93E; and G.M. Ecciest~, "Multiple-Phase Oil-In-Water Emulsion," 41 J. Soc. Cosmet. Chem. 1-22, (January/Febniary 1990)'.
The compositions herein have desirable aesthetic and elegant properties, such as a rich and creamy, yet non-greasy, skin feel. These compositions can span a broad range of consistencies from thin Lotions to heavy creams. These compositions typically have viscosities ranging from about 100 cps to about 500,000 cps, preferably from about 3,000 cps to about 200,000 cps, more preferably ~~ i I , .F~ -, tI I-'_ ~I - . i ,~ , , .
WO 97/28785 ) j PCTIUS97101170 from about 5000 cps to about 150,000 cps, as measured at a temperature of ?5°C with a Brookfieid Synchro-Lectric Viscometer Model D. The compositions can span a wide range of pH values. ~ven though buffers can be utilized to help maintain the pH of the emulsion compositions, these are not required components, but are merely optional ingredients.
The compositions of the present invention comprise the following essential components.
These components should be pharmaceutically acceptable.
sunscreen Anent The compositions of the present invention comprise from about 0.1% to about 30%, more preferably from about 0.5% to about 25%, sad most preferably from about 1% to about 20% of the compositions of the present invention. Mixtures of sunscreen agents can also be used. Exact amounts of sunscreen agent will vary depending upon the sunscreen or sunscreens chosen and the desired Sun Protection Factor (SPF) to be achieved. SPF is a commonly used measure of photoprotection of a sunscreen against etythema. The SPF is defined as the ratio of the ultraviolet energy required to produce minimal erythema on protected skin to that required to produce the same minimal erythema on unprotected akin in the same individual. S,~ Federal Resister. Vol. 43, No.
166, pp. 38206-38269, August 25, 1978;.
A wide variety of sunscreen agents are useftrt herein. These sunscreen agents include both organic compounds and their salts as well as inorganic particulate materials.
Without being limited by theory, it is believed that sunsctt~ett agents provide protection 1mm ultraviolet t~adisti~ by one or more of the following mechanisms including absorption, scattering, and reflection of the ultraviolet radiation. Nonlimiaag examples of these sunscreen agents are described in U.S.
Patent No.
5,087,445, to Haffey et al., issued February 1 l, 1992; U.S. Patent No.
5,073,372, to Turner et al., issued December 1?, 1991; U.S. Patent No. 5,073,371, to Turner et al. issued December 17, 1991;
U.S. Patsnt No. 5,160,731, to Sabatelli et al., issued November 3, 1992; U.S.
Patent No. 5,138,089, to SabateUi, issued August 11, 1992; U.S. Patent No. 5,041,282, to Sabatelli, issued August 20, 1991;
U.S. Patent No. 4,999,186, to Sabatelli et aL, issued March 12, 1991; U.S.
Patent No. 4,937,370, to Sabatelli, issued Juae 26, 1990; and Segarin, et al., at Chapter VIII, pages 189 et seq., of o tics f fence gel Tcchttoloev;.
Pamong the sunxreen agents are those selected from the group consisting of 2-ethylhexyl p-methoxycinnamate, octyl salicylate, octocrylene, oxybenzone.
2~ethylhexyl N,N-dimethylaminobenzoate, p-aminobenzoic acid, 2-phenyl-benzimidazole-5~sulfonic acid, homomeuthyl _~iicyhtte, DEA p~mettioxycinnamate, 4,4'methoxy-t-buryidibenzoyhnethane, 4~
isopropyldibenzoylmethane, 3-(4-methylbenrytidene) camphor, 3-benryGdene camphor, 4-N,N-dimethylaminobenzoic acid ester with 2,4-dihydroxybenzophenone, 4-N,N-dimethyiaminobenzoic acid ester with 2-hydroxy-4-(2-hydroxyethoxy)benmphenone, 4-N,N-dimethylaminobenzoic acid ester with 4-hydroxydibanzoyi- methane, 4-N,N-dimethylaminobenmic acid ester with 4-(2-hydroxyethoxy~ibenzoylmethane, 4-N,N-di(2-tthylhexyl~ aminobenzoic acid ester with 2,4-W O 9728785 PCTlLTS97101170 dihydroxybenzophenone, 4-N,N-di(2-ethyihexyl)aminobenzoic acid ester with 2-hydroxy-4-(2 hydroxyethoxy)benzophenone, 4-N,N-di(2-ethylhexyl)aminobenzoic acid ester with 4-hy droxydibenzoyhnethane, 4-N,N-di(2-ethylhexyl)aminobenzoic acid ester with 4-(2-hydroxyeth oxy)dibenzoylmethane, 4-N,N-(2-ethylhexyl)methylaminobenzoic acid ester with 2,4 dihydroxybenzophenone, 4-N,N-(2-ethylhexyl)methylaminobenzoic acid ester with 2-hydroxy-4-(2 hydroxyethoxy)benzophenone, 4-N,N-(2-ethylhexyl)methylaminobenzoic acid ester with 4-hy r droxydibenzoylmethane, 4-N,N-(2-ethylhexyl)methylaminobenzoic acid ester with 4-(2-hydroxyeth-oxy)dibenzoylmethane, titanium dioxide, zinc oxide, iron oxide, and mixtures thereof.
More preferred for use in the compositions described herein are the sunscreen agents selected from the group consisting of 2-ethylhexyl N,N-dimethyl-p-amittobenzoate, 2-ethylhexyl p-methoxycinnamate, octocrylene, octyl salicylate, homomenthyi salicyiate, p-aminobenzoic acid, oxybenzone, 2-phenylbenzimidazole-5-sulfonic acid, DEA p-methoxycinnamate, 4,4'-methoxy-t-butyldibenzoylmethane, 4-isopropyl dibenzoyhnethane, 3-(4-methylbenzylidene) camphor, 3-benzylidene camphor, 4-N,N-(2-ethylhexyl)methylaminobenzoic acid ester with 4-(2-hydroxyeth-oxy)dibenzoylmethane, titanium dioxide, zinc oxide, iron oxide, and mixtures thereof.
Even more preferred for use in the compositions described herein are the sunscreen agents selected from the group consisting of 2-ethylhexyl N,N-dimethyl-p-aminobenzoate, 2-ethylhexyl p-methoxycinnamate, octocrylene, octyl salicylate, oxybenzone, 2-phenylbenzimidazole-5-sulfonic acid, 4,4'-methoxy-t-buyldibenzoylmethane, 3-(4-methylbenzylidene) camphor, 3-benzylidene camphor, 4-N,N-(2-ethylhexyl)methylaminobenzoic acid ester with 4-(2-hydroxyeth-oxy)dibenzoylmethane, titanium dixoide, zinc oxide, iron oxide, and mixtures thereof.
Most preferred for use in the compositions of the present invention are the sunscreen agents selected from he group consisting of 2-ethylhexyl p-methoxycinnamate, 4,4'-methoxy-t-buyldibenzoylmethane, zinc oxide, and mixtures thereof.

wo m2s~ss - ~ ) ~ PCTIUS9'7101170 Strpcturing_~gent The present invention comprises from about 0.5% to about 20%, preferably from about 1% to about 10%, and more preferably from about I% to about 5%, of a hydrophobic, structuring agent selected from the group consisting of saturated C 16 to C30 fatty alcohols, saturated C 16 to C30 fatty aicohots containing from about 1 to about 5 moles of ethylene oxide, saturated C 16 to C3p diols, saturated C 16 to C30 monoglycerol ethers, saturated C 16 to C3p hydroxy fatty acids, and mixtures xhereof, having a melting point of at least about 40°C. Without being limited by theory, it is believed that these structuring agents are useful to assist in the formation of the theological characteristic of the composition which contrihute to the hydrolytic stability of the composition of the present invention. In particular sweturing agents assist in the formation of the liquid crystalline gel nccwork structures.
The preferred structuring agents of the present invention are selected from the group consisting of stearyi alcohol, ceryl alcohol, behenyl alcohol, stearic acid, palmitic acid, the polyethylene glycol ether of stearyl alcohol having an average of about 1 to about 5 ethylene oxide units, the polyethylene glycol edter of ceryl alcohol having an average of about I to about 5 ethylene oxide units, and mixtures thereof. More preferred structuring agents of the present invention are selected from the group consisting of stearyl alcohol, ceryl alcohol, beheayl alcohol, the polyethylene glycol ether of stearyl alcohol having an average of about 2 ethylene oxide units (stearcth-2), the polyethylene glycol ether of ceryl alcohol having an average of about 2 ethylene oxide units, and mixtures thereof. Even more preferred strucauing agents are selected from the group consisting of stearyl alcohol, cetyl alcohol, behenyl alcohol, steateth-2, and mixtures thereof. F~vdroohilic Sub The compositions of the present invention comprise from about 0.2% to about 10%, preferably from about 0.2°Y. to about 6%, and.more preferably from about 0.2% to about 3% of at least one hydrophilic atufactartt. Without being limited by theory, it is believed that the hydrophilic surfactant disperses the hydrophobic materials, i.e. the structuring agent, in the water phase. The surfacnat, at a minimum, must be hydrophilic enough to disperse in water.
The surfactants useful herein can include any of a wide variety of cationic, anionic, iwi~ertbttic, aad amphoteric surfactants disclosed in prior patents and other references. She McCutcheon's, ~etaaeats and Emulsifiers. North American Edition ( 1986), published by Allured Publishing Corporation; U.S. Patent No. 5,011,681 to Ciotti et al., issued April 30, 1991; U.S. Patent No. 4,421,769 to Dixon et al., issued December 20, 1983; and U.S. Patent No.
3,755,560 to Dickert et al., issued August 28, i973~.
The exact surfactant chosen will depend upon the pH of the composition and the other components present.

PTO 9~f28785 PCT/US97/01170 Preferred for use herein are nonionic surfactants. Among the nonionic surfactants that are useful herein are those that can be broadly defined as condensation products of long chain alcohols, e.g. C8-30 alcohols, with sugar or starch polymers, i.e., glycosides. These compounds can be represented by the formula (S)n-O-R wherein S is a sugar moiety such as glucose, fructose, mannose, and galactose; n is an integer of from about I to about 1000, and R
is a C8-30 alkyl group.
Examples of long chain alcohols from which the alkyl group can be derived include decyl alcohol, cetyl alcohol, stearyl alcohol, lauryl alcohol, myristyl alcohol, oleyl alcohol, and the tike. Preferred examples of these surfactants include those wherein S is a glucose moiety, R
is a C8-20 alkyl group, and n is an integer of from about 1 to about 9. Commercially available examples of these surfactants include decyl polyglucoside (available as APG 325 CS from Henkel) and lauryl polyglucoside (available as APG 600 CS and 625 CS from Henkel).
Other useful nonionic surfactants include the condensation products of alkylene oxides with fatty acids (i.e. alkyiene oxide esters of fatty acids). These materials have the general formula RCO(X)nOH wherein R is a C10-30 alkyl group, X is -OCH2CH2- (i.e. derived from ethylene glycol or oxide) or -OCH2CHCH3- (i.e. derived from propylene glycol or oxide), and n is an integer from about 6 to about 100. Outer nonionic surfactants are the condensation products of alkylene oxides with 2 moles of fatty acids (i.e. alkylene oxide diesters of fatty acids). These materials have the general formula RCO(X)nOOCR wherein R is a CIO-30 alkyl group, X is -OCH2CH2-(i.e.
derived from ethylene glycol or oxide) or -OCH2CHCH3-(i.e. derived from propylene glycol or oxide), and n is an integer from about 6 to about 100. Other nonionic surfactants are the condensation products of alkylene oxides with fatty alcohols (i.e. aIkylene oxide ethers of fatty alcohols). These materials have the general formula R(X)nOR' wherein R is a C10-30 alkyl group, X is -OCH2CH2-(i.e. derived from ethylene glycol or oxide) or -OCH2CHCH3-(i.e. derived from propylene glycol or oxide), and n is an integer from about 6 to about 100 and R' is H or a C10-30 alkyl group. Still other nonionic surfactants are the condensation products of alkylene oxides with both fatty acids and fatty alcohols [i.e. wherein the polyalkylene oxide portion is esterified on one end with a fatty acid and etherified (i.e. connected via an ether linkage) on the other end with a fatty alcohol]. These materials have the general formula RCO(X)nOR' wherein R and R' are C I 0-30 allcyt groups, X is -OCH2CH2 (i.e. derived from ethylene glycol or oxide) or -(derived from propylene glycol or oxide), and n is an integer from about 6 to about 100.
Nonlimiting examples of these alkylene oxide derived nonionic surfactants include ceteth-6, ceteth-10, ceteth-12, ceteareth-6, ceteareth-I0, ceteareth-12, steareth-6, steareth-10, steareth-12, PEG-6 stearate, PEG-10 stearate, PEG-12 stearate, PEG-20 glyceryl stearate, PEG-80 glyceryl tallowate, PPG-10 glyceryl stearate, PEG-30 glyceryl cocoate, PEG-80 glyceryl cocoate, PEG-200 glyceryl tallowate, PEG-8 dilaurate, PEG-10 distearate, and mixtures thereof.
Still other useful nonionic surfactants include polyhydroxy fatty acid amide surfactants corresponding to the structwal formula:

~ , l 's ~ ~i l 1l WO 97128785 _ _ ) \~ P~~S97I01170 R2 C N Z .

wherein: R1 is H, C 1-C4 alkyl, 2-hydroxyethyl, 2-hydroxy- propyl, preferably C 1-C4 alfryl, more preferably methyl or ethyl, most preferably methyl; R2 is CS-C31 alkyl or .alkenyl, preferably C7-Clg alkyl or alkenyl, more preferably C9 C17 alkyl or alkenyl, most preferably C11-C15 aryl or alkenyl; and Z is a polhydroxyhydrocatbyl moiety having a linear hydrocarbyi chain with a least 3 hydroxyls directly connected to the chain, or an alkoxylated derivative (preferably ethoxylated or propoxyiated) thereof. Z preferably is a sugar moiety selected from the group consisting of glucose, fructose, maltose, lactose, gaiaetose, mannose, xylose, and mixturrs thereof.
An especially preferred surfactant corresponding to the above structure is coconut alkyl N-methyl glucoside amide (1.e., wherein the R2C0- moiety. is derived from coconut oil fatty acids). Processes for matting compositions containing polyhydruxy fatty acid amides are disclosed, for example, in G.B. Patent Specification 809,060, published February 18, 1959, by Thomas Hedley & Co., i,td.; U.S. Patent No. 2,961,176, to E.R. Wilson, issued December 20, 1960; U.S. Patent No.
2,703,798, to A.M.
Schwaru, issued March 8, 1955; and U.S. Patent No. 1,985,424, to Piftaott.
issued December 25, 1934;.
Preferred among the nonionic suRactartts are those selected from the group consisting of stear~eth-21, ceteareth-20, ceteareth-12, sucrose cocoate, steareth-100, PEG-100 stearate,. and mixtures thereof.
A wide variety of cationic smfactartts useful herein are disclosed in U.S.
Patent No.
5,151,209, to McCall et al., issued September 29, 1992; U.S. Patent No.
1,151,210, to Steuri et al., issued September 29, 1992; U.S. Patent No. 5,120,532, to Wells et al., issued June 9, 1992; U.S.
Patent No. 4,387,090, to Bolich, issued June 7, 1983;; U.S. Patent 3,155,591, Hilfer, issued November 3, 1964; U.S. Patent No. 3,929,678, to Iaulghlin et al., issued December 30, 1975; U.S.
Patettt No. 3,959,461, to Bailey et al.,~ issued May 25, 1976; McCutcheo~t's.
Detergents &
ml 1 a (North American edition 1979) M.C. Publishing Co.; and Schwartz, et al., S ace Active Agents. their Chemises "~ d~,'~echnoloav, New York: ~ lnterxience Publishers, 194.
The cationic surfactants useful herein include cationic ammoniuar salts such as those having the formula:

WO 97128785 PCT/US97I011'10 R2'-fl --R3 X
wherein Rl, is an alkyl group having from about t2 to about 30 carbon atoms, or an aromatic, aryl or alkaryl groups having from about 12 to about 30 carbon atoms; R2, R3, and R4 are independently selected from hydrogen, an allcyl group having from about 1 to about 22 carbon atoms, or aromatic, aryl or alkaryl groups having from about 12 to about 22 carbon atoms; and X is any compatible anion, preferably selected from the group consisting of chloride, bromide, iodide, acetate, phosphate, nitrate, sulfate, methyl sulfate, ethyl sulfate, tosylate, lactate, citrate, glycolate, and mixtures thereof.
Additionally, the alkyl groups of R1, R2, R3, and R4 can also contain ester and/or ether linkages, or hydroxy or amino group substituents (e.g., the alkyl groups can contain polyethylene glycol and polypropylene glycol moieties).
More preferably, R1 is an alkyl group having from about 12 to about 22 carbon atoms; R2 is selected from H or an alkyl group having from about 1 to about 22 carbon atoms; R3 and R4 are independently selected from H or an alkyl group having from about 1 to about 3 carbon atoms; and X is as described previously.
Most preferably, Rl is an alkyl group having from about 12 to about 22 carbon atoms; R2, R3, and R4 are selected from H or an alkyl group having from about 1 to about 3 carbon atoms; and X is as described previously.
Alternatively, other useful cationic emulsifiers include amino-amides, wherein in the above structure Rl is alternatively RgCONH-(CH2)n , wherein R5 is an alkyl group having from about 12 to about 22 carbon atoms, and n is an integer from about 2 to about 6, more preferably from about 2 to about 4, and most preferably from about 2 to about 3. Nonlimiting examples of these cationic emulsifiers include stearamidopropyl PG-dimonium chloride phosphate, behenamidopropyl PG
dimonium chloride, stearamidopropyl ethyldimonium ethosulfate, stearamidopropyl dimethyl (myristyl acetate) ammonium chloride, stearamidopropyl dimethyl cetearyl ammonium tosylate, steassatnidopropyl dimethyl ammonium chloride, stearamidopropyl dimethyl ammonium lactate, and mixtures thereof. Especially preferred is behenamidopropyl PG dimonium chloride.
Nonlimiting examples of quaternary ammonium salt cationic surfactants include those selected from the group consisting of cetyl ammonium chloride, cetyl ammonium bromide, lauryl ammonium chloride, lauryl ammonium bromide, stearyl ammonium chloride, stearyl ammonium bromide, cetyl dimethyl ammonium chloride, cetyl dimethyl ammonium bromide, lauryl dimethyl ammonium chloride, lauryl dimethyl ammonium bromide, stearyi dimethyl ammonium chloride, stearyl dimethyl ammonium bromide, cetyl trimethyl ammonium chloride, cetyl trimethyl ammonium bromide, lauryl trimethyl ammonium chloride, lauryl trimethyl ammonium bromide, WO 97/28785 _ ~ ~ P~/US97101170 t0 stearyi trimethyl ammonium chloride, stearyl trimethyt ammonium bromide, lauryl dimethyl ammonium chloride, stearyl dimethyl ceryl ditallow dimethyl ammonium chloride.
dicetyl.
ammonium chloride, dicetyl ammonium bromide, dilauryl ammonium chloride, dilauryl ammonium bromide, distearyl ammonium chloride, distearyl ammonium bromide, diceryl methyl ammonium chloride, dicetyl mtthyl aci~monium bromide, dilauryl methyl ammonium chloride, diiauryl methyl ammonium bromide, distearyl methyl ammonium chloride, distearyl methyl ammonium bromide, and mixtures thereof. Additional quaternary ammonium salts include those wherein the C 12 to C3p alkyl carban chain is derived from a tallow fatty acid or from a coconut fatty acid. The term "tallow"
refers to an alkyl group derived from tallow fatty acids (usually hydrogenated tallow fatty acids), which generally have mixtures of alkyl chains in the C 16 to C 1 g range. The term "coconut" refers to an alkyl group derived from a coconut fatty acid, which generally have mixtures of alkyl chains in the C l ~ to C 14. range. Examples of quaternary ammonium salts derived from these tallow and coconut sources include ditallow dimethyl ammonium chloride, ditallow dimethyl ammonium methyl sulfate, di{hydrogenated tallow) dimethyl ammonium chloride, di(hydrogenated tallow) dimethyl ammonium acetate, ditallow dipropyl ammonium phosphate, ditallow dimethyl ammonium nitrate, di(coconutalkyl~imethyl ammonium chloride, di(coconutaUcyl~imethyl ammonium bromide, tallow ammonium chloride, coconut ammonium chloride, stearamidopropyl PG.dimonium chloride phosphate, stearamidopropyl ethyldimonium ethosulfate, stearamidopropyt dimethyl (myristyl acetate) ammonium chloride, stearamidopropyl dimethyl cetearyl ammonium tosylate, stearamidopropyl dimethyl amruonium chloride, stearamidopropyl dimethyl ammonium lactate, and mixtures thereof. An example of a quaternary ammonium compound having an alkyl group with an . ester linkage is ditallowyl oxyethyl dimethyl ammonium chloride.
Morn preferred cationic surfactants are those selected from the group consisting of behenamidopmpyl PG dimonium chloride, dilauryl dimethyl ammonium chloride, distearyl dimethyl ammonium chloride, dimyristyl dimethyl ammonium chloride, dipatmityl dimethyl ammonium chloride, dietary! dimelttyl ammonium chloride, stestamidopropyl FG-dimonium chloride phosphate. s~idoProPYI ~Yl~onium ethosulfate, uearamidoproPYl dimethyl (myristyl acetate) ammonium chloride, stearamidopropyl ditnethyl cetearyl ammonium tosylate, ~amyyl dimethyl ammonium chloride, susramidopropyl dimethyl ammonium lactate, and mixtures thereof.
Most preferred cationic surfactants are those selected from the group consisting of behenamidopropyl PG dimonium chloride, dilauryl dimethyl ammonium chloride, distearyl dimethyl ammonium chloride, dimyristyl dirnethyl ammonium chloride, dipalmityl dimethyl ammonium chloride, and mixtures thereof.
A wide variety of anionic surfactants are also useful herein. ,~,e~, e.g., U.S. Patent No.
3,929,678, to Laughlin et al., issued December 30, 1475,.
Nonlimiting examples of anionic surfactsats include the alkoyl isethionates, and the I ~~ '; '; d', I i1 WO 97!28785 ~ P~ PCT/U&9'7101170 '"
alkyl and alkyl ether sulfates. The aikoyi isethionates typically have the formula RCO-OCH~CH~SO~M wherein R is alkyl or alkenyt of from about 10 to about 30 carbon atoms, and M is a water-soluble canon such as ammonium, sodium, potassium and triethanolamine.
Nonlimiting examples of these isethionates include those alkoyl isethionates selected from the group consisting of ammonium cocoyl isethionate. sodium cocoyl isethionate, sodium lauroyl isethionate, sodium stearoyl isethionate, and mixtures thereof The alkyl and alkyl ether sulfates typically have the respective formulae ROSO~M and RO(C2H40)xS03M, wherein R is allcyl or alkenyl of from about 10 to about 30 carbon atoms, x is from about 1 to about 10, and M is a water-soluble cation such as ammonium, sodiutn, potassium and triethanoiamine. Another suitable class of anionic surfactants are the water-soluble satts of the organic, sulfuric acid reaction products of the general formula:
R l _S03._M
wherein RI is chosen from the group consisting of a straight or branched chain, saturated aliphatic hydrocarbon radical having from about 8 to about 24, preferably about l0 to about 16, carbon atoms;
and M is a canon. Still other anionic synthetic . surfactants include the class designated as succinamates, olefus sulfonates having about 12 to about 24 carbon atoms, and b-alkyloxy alkane sulfonates. Examples of these materials are sodium lauryl sulfate and ammonium lauryl sulfate.
Other anionic materials useful herein are soaps (i.e. alkali metal salts, e.g., sodium or potassium salts) of fatty acids, typically having from about 8 to about 24 carbon atoms, preferably from about 10 to about 20 carbon atoms: The fariy acids used in making the soaps can be obtained from natural sources such as, for instance, plant or animal-derived glycerides (e.g., palm oil, coconut oil, soybean oil, castor oil, tallow, lard, etc.) The fatty acids can also be synthetically prepared.
Soaps are described in more detail in U.S. Parcel No. 4,557,853, cited above.
,..
Amphoteric and zwitterionic surfactants are also useful herein. Examples of amphoteric and zwitterionic surfactants which can be used in the compositions of the present invention are those which are broadly described as derivatives.of aliphatic secondary and tertiary amines in whioh the aliphatic radical can be straight or branched chain and wherein one of the aliphatic substiments contains from about 8 to about 22 carbon atoms (preferably Cg - C l g) and one contains an anionic vuatEi solubilizing group, e.g., carboxy, sulfonate, sulfate, phosphate, or phosphonate. Examples are alkyl imino acetates, and iminodialkanoates and aminoafkanoates of the formulas RN[CH2)mC02M]2 and RNH(CH2)mC02M whereiq m is from 1 to 4, R is a Cg-C~ alkyl or alkenyi, and M is H, alkali metal, alkaline earth mete! ammonium, or alkanolammonium. Also included are imidazolinium and ammonium derivatives. Specific examples of suitable amphoteric surfactants include sodium 3-dodecyl-aminopropionate, sodium 3-dodecylaminopropans sulfonate, N-alkyltaurines such as the one prepared by reacting dodecylamine with sodium isethionate according to the teaching of U.S. Patent 2,658,072~~
N-higher alkyl aspartic acids such as those produced according to the teaching of U.S.

' WO 97128785 ~ ~ PCT/LTS97l01170 l '' Patent 2,438.091 ~ and the -products sold under the trade name "Miranol" and described in U.S, Patent 2,528.378 Other examples of useful amphottrics include phosphates, such as coamidopropyl PG-dimonium chloride phosphate (commercially available as Monaquat PTC, from Mona Corp.).
Also useful herein as amphoteric or zwitterionic surfactanu are the betaines.
Examples of betaines include the higher alkyl betaines, such as coco dimethyl carboxymethyl betaine, lauryl dimethyl carboxymethyl ixtaine, iauryl dimethyl alphacarboxyethyl betaine, -cetyl dimethyl carboxymethyl betaine, cetyl dimethyl betaine (available as Lonzaine 16SP from Lonza Corp.), Isuryl bis-(2-hydtoxyethyl) carboxymetttyl betaine, stearyl bis-(2-hydroxypropyl) carboxymethyl betaime, oleyl dimethyl gamma-catboxypropyl betaine, lauryl bis-(2-hydmxypropyl)alpha -carboxyethyl betaine, coco dimethyl sulfopropyi betaine, stearyl dimethyl sulfopropyl betaine, lauryl dimethyl sulfoethyl betaine; lauryl bis-(2-hydroxyethyl) sulfopropyl betaine, and amidobetaines and amidosulfobetaines (wherein the RCONH(CHZ)3 radical is attached to t[ie nitrogen atom of the betaine), oleyl betaine (available as amphoteric Velvetex OLB-i0 from .*
Henkel), and cocamidopropyl betaine (available as Velvetex BK-35 and, BA-3S
from Henkel).
Other useful amphoteric and zwitterionic surfac~ttts include the suhaincs and hydroxysultaines such as cocamidopropyl hydroxysultaine (available as Mirataine CBS from Rhone-Poulenc), and the alkanoyl sarcosinates corresponding to the formula RCON(CH3xH2CH2C02M wherein R is alkyl or alkenyl of about 10 to about 20 carbon atoms, and M is a water-soluble cation such as ammonium, sodium, potassium and trialkanolamine (e.g., triethanolamine), a preferred example of which is sodium lauroyl sarcosinate.
Thickenine Aeent The compositions of the present invention can also comprise from about 0.1% to about 5%, more preferably from about 0.1 % to about 3%, and most preferably from about 0.25% to about 2%
of a thickening agent.
Noalimitimg classes of thickening agents include those selected from the group consisting of carboxylic acid polymers, crosstinked polyacrylate polymers, polyacrylamide polymers, pol~rsaacharides, gums, vinyl ether/maleic anhydride copolymers, crosslinked poly(N-vinylpyrrolidones), and mixtures thereof. Preferred thickening agents are those selected from the group consisting of carboxylic acid polymers, crossiinked polyacrylate polymers, polyacrylamide polymers, and mixtures thereof. More prefemd thickening agents are those selected form the group consisting of crosslinked polyacrylate polymers, plyacrylamide polymers, and mixtures thereof. eey U.S. Patent No., 4,387,107, to Klein et al., issued June 7, 1983 and "Encyclopedia of Polymer and Thickeners for Cosmetics," RY. Lochhead and W.R. Fron, eds., Cosmetics &
Toiletries, vol. 108, pp. 95-135 (May 1993), which list a variety of thickeming or gelling agents;.
, * Trademark ~, ,, . ~ I I i1 WO 97/Z8785 ~ _~ p~~S97101170 i3 Carboxylic Acid Polymers These polymers are crosslinked compounds containing one or more monomers derived from acrylic acid, substituted acrylic acids, and salts and esters of these acrylic acids and the substituted acrylic acids, wherein the crosslinking agent contains two or more carbon-carbon double bonds and is derived from a polyhydric alcohol. The preferred carboxylic acid polymers are of two general types. The fu~st type of polymer is a crosslinked homopolymer of an acrylic acid monomer or derivative thereof (e.g., wherein the acrylic acid has substituenis on the two and three carbon positions independently selected from the group consisting of C alkyl, -CN, -1.4 COOH, and mixtures thereof). The second type of polymer is a crosslinked copolymer having a first monomer selected from the group consisting of an acrylic acid monomer or derivative thereof (as just described in the previous sentence), a short chain alcohol (i.e., a C I
~) acryiate ester monomer or derivative thereof (e.g., wherein the acrylic acid portion of the ester has substitueats on the two and three carbon positions independently sclecttd from the group consisting of Cl~
alkyl, -CN, COOH, and mixtures thereof), and mixtures thereof: and a second monomer which is a long chain alcohol (i.e. C8~0) acrylate ester monomer or derivative thereof (e.g., wherein the acrylic acid portion of the ester has substitusnts on the two and three carbon positions independently selected from the group consisting of C alkyl, -CN, -COOH, and mixtures thereof).
Combinations of these two types of polymers are also useful herein.
In the first type of crosslinked homopolymers, the monomers are preferably selected from the group consisting of acrylic acid, methacrylic acid, ethacrylie acid, and mixtures thereof, with acrylic acid being most preferred. In the second type of crosslinlced copolymers the acrylic acid monomer or derivative thereof is preferably selected from the group consisting of acrylic acid, methacrylic acid, ethacrylic acid, and mixtures thereof, with acrylic acid, methacrylic acid, and mixtures thereof being most prefernd. The short chain alcohol acrylate ester mpnomer or derivative thereof is preferably selected from the group consisting of C alcohol acrylate esters, C
alcohol methacryiate esters, C alcohol ethacrylate esters, and rnixtur~es thereof, with the C alcohol acrylate esters, C alcohol methacrylate esters, and mixtures thereof, being most preferred. The long chain alcoh t~acryfate ester monomer is selected from CB~ alkyl acrylate esters, with C1~30 alkyl acrylate esters being pzeferred The cmsslinking agent in both of these types of polymers is a polyalkenyl polyether of a polyhydric alcohol containing more than one alkenyl ether group per molecule, wherein the parent poiyhydric alcohol contains at least 3 carbon ata~ras and at least 3 hydroxyl groups. Preferred crosslinkers are those selected from the group consisting of allyl ethers of sucrose and allyl ethers of pentaerythritol, snd mixtures thereof. These polymers useful in the present invention are more fully described in U.S. Patent No. 5,087,445, to Haffey et al., issued February 11, 1992; U.S. Patent No.
4,509,949, to Huang et al., issued April 5, 1985; U.S. Patent No. 2,798,053, to Bmwn, issued July 2, 1957;, See also, (x,TFA International I H a~ I ~I

WO 97128785 ~ j PCTIUS97/OI170 C9~metic Ingre,øient Dictionary, fourth edition, 1991, pp. 1? and 80'.
Examples of commercially available homopolymtrs of the first type useful herein includt the carbomers, which are homopoiymers of acrylic acid crosslinked with allyl ethers of sucrose or pentaerytritol. The carbomers are available as the Carbopol~ 900 series from B.F. Goodrich.
Examples of commercially available copolymers of the second type useful herein include copolymers of C alkyl acrylates with one or more monomers of acrylic acid, methacrylic acid, or one of their short chin (i.e. C alcohol} esters, wherein the crosslinking agent is an aliyl ether of sucrose or pentaerytritol. These copolymers are known as acrylateslClO-30 alkyl acrylate crosspolymers and are commercially available as Carbopol~ 1342, Pemuien TR-1, and Pemulen TR-2, from B.F. Goodrich. In other words, examples of carboxylic acid polymer thickeners useful herein are those selected from the group consisting of carbomers, acryiates/C10-C30 alkyl acrylace crosspolymers, and mixtures thereof.
Cros~~c d Polvacrvlate Po~vmers 'The crosslinked.polyacrylate polymers useful as thickeners or gelling agents include both cationic and nonionic polymers, with the cationics being generally preferred. Examples of useful crosslinked nonionic polyacrylate polymers and crosslinked cationic polyacrylste polymers are those described in U.S. Patent 5,100,660, to Hawe et al., issued March 31, 1992; U.S. Patent 4,849,x84, to Heard, issued July 18, 1989; U.S. Patent 4,835,206, to Farrar et al., issued May 30, 1989; U.S. Patent 4,628,078 to Glover et al. issued December 9, 1986; U.S. Patent 4,599,379 to Fieslter et al. issued July 8, 1986; and EP 228,868, to Farrar et al., published July 15, 1987..
The crosslinked polyacryiate polymers are high molecular weight materials that can be characterized by the general formula: (A) (B) (C) and comprise the monomer units (A) , (B) , and t m n I m (C) , wherein (A) is a dialkylaminoalkyl acrylate monomer or its quaternary ammonium or acid adduion salt, (B) is a diaikylaminosiky! methacryiate monomer or its quaternary ammonium o~ acid addition salt, (C) is a monomer that is polymerimble with (A) or (H), for example a monomer having a carbon-carbon double bond or other such polymerizable functional group, 1 is an integer of 0 or greater, m is an integer of 0 or grcatet, n is an integer of 0 or greater, but where either 1 or m, or both, riw~ be 1 a gr~r.
The (C) monomer can be selected from any of tile commonly used monomers.
Nonlimiting examples of these mmtomers include ethylene, propylene, butylene, isobutyleae, eicosene, malefic aahydride, acrylamide, medtacrylamide, malefic acid, acrolein, cyclohexene, ethyl vinyl ether, and methyl vinyl ether. In the cationic polymers of the present invention, (C) is preferably acrylamide:
The alkyl portions of the (A) and (B) monomers ,are short chain length alkyls such as C1-C8, preferably C -C , more preferably C -C , and most preferably C -C . When quatemzied, the polymers are preferably quaternized with short chain alkyls, i.e., C -C , preferably C -C , more preferably C -C , and most preferably C -C . The acid addition salts refer to polymers having WO 97128785 PCTlUS97101170 protonated amino groups. Acid addition salts can be performed through the use of halogen (e.g.
chloride), acetic, phosphoric, nitric, citric, or other acids.
These (A)1(B}m(C)n polymers also comprise a crosslinking agent, which is most typically a material containing two or more unsaturated functional groups. The crossIinking agent is reacted with the monomer units of the polymer and is incorporated into the polymer thereby forming Links or covalent bonds between two or more individual polymer chains or between two or more sections of the same polymer chain. Nonlimiting examples of suitable crosslinking agents include those selected from the group consisting of methylenebisacrylamides, diallyldialkyl ammonium halides, poiyalkenyl polyethers of polyhydric alcohols, ally( acrylates, vinyloxyalkylacrylates, and polyfunctional vinyiidenes. Specific examples of crosslinking agents useful herein include those selected from the group consisting of methylenebisacrylamide, ethylene glycol di-(meth)acrylate, di-(meth)acrylamide, cyanomethyiacrylate, vinyloxyethylacrylate, vinyloxyethylmethacrylate, allyi pentaerythritol, trimethylolpropane diallylether, ally( sucrose, butadiene, isoprene, divinyl benzene, divinyf naphthalene, ethyl vinyl ether, methyl vinyl ether, and ally( acrylate. Other crosslintcers include formaldehyde and glyoxal. Preferred for use herein as a crosslinking agent is methylenebisacrylamide.
Widely varying amounts of the crosslinking agent can be employed depending upon the properties desired in the final polymer, e.g. viscosifying effect. Without being limited by theory, it is believed that incorporation of a crosslinking agent into these cationic polymers provides a material that is a more effective viscosifying agent without negatives such as stringiness and viscosity breakdown in the presence of electrolytes. The crosslinking agent, when present, can comprise from about 1 ppm to about 1000 ppm, preferably from about 5 ppm to about 7S0 ppm, more preferably from about 25 ppm to about S00 ppm, even more preferably from about 100 ppm to about S00 ppm, and most preferably from about 250 ppm to about 500 ppm of the total weight of the polymer on a weightlweight basis.
The intrinsic viscosity of the crosslinked polymer, measured in one molar sodium chloride solution at 2S C, is generally above 6, preferably from about 8 to about 14.
The molecular weight (weight average) of the crosslinked polymers hereof is high, and is believed to typically be between about v million and about 30 million. The specific molecular weight is not critical and lower or higher weight average molecular weights can be used as long as the polymer retains its intended viscosifying effects. Preferably, a 1.0% solution of the polymer (on an actives basis} in deionized water will have a viscosity at 2S C of at least about 20,000 cP, preferably at least about 30,000 cP, when measured at 20 RPM by a Brookfield RVT (Brookfield Engineering Laboratories, Inc.
Stoughton, MA, USA).
These cationic polymers can be made by polymerization of an aqueous solution containing from about 20% to about 60%, generally from about 25% to about 40%, by weight monomer, in the presence of an initiator (usually redox or thermal) until the polymerization terminates. The WO 97!28785 PCT/US97/O1I70 crosslinking agent can also be added to the solution of the monomers to be polymerized, to incorporate it into the polymer. In the polymerization reactions, the temperature generally starts between about O and 95 C. The polymerization can be conducted by forming a reverse phase dispersion of an aqueous phase of the monomers (and also any additional crosslinking agents} into a nonaqueous liquid, e.g. mineral oil, Lanolin, isododecane, oleyl alcohol, and other volatile and nonvolatile esters, ethers, and alcohols, and the like.
All percentages describing the polymer in this section of the description herein are molar, unless otherwise specified. When the polymer contains (C) monomer, the molar proportion of (C) monomer, based on the total molar amount of (A), (B), and (C), can be from 0%
to about 99%. The molar proportions of (A) and (B) can each be from 0% to 100%. When acrylamide, is used as the (C) monomer, it will preferably be used at a level of from about 20% to about 99%, more preferably from about 50% to about 90%.
Where monomer (A) and (B) are both present, the ratio of monomer (A} to monomer (B) in the final polymer, on a molar basis, is preferably from about 99:5 to about 15:85, more preferably from about 80:20 to about 20:80. Alternatively, in another class of polymers, the ratio is from about 5:95 to about 50:50, preferably from about 5:95 to about 25:75.
In another alternative class of polymers, the ratio (A):(B) is from about 50:50 to about 85:1 S.
Preferably the ratio (A):(B) is about 60:40 to about 85:15, most preferably about 75:25 to about 85:15.
Most preferred is where monomer (A) is not present and the ratio of monomer (B):monomer (C) is from about 30:70 to about 70:30, preferably from about 40:60 to about 60:40 and most preferably from about 45:55 to about 55:45.
Cationic polymers that are useful herein that are especially preferred are those conforming to the general structure (A)1(B)m(C)n wherein 1 is zero, (B) is methyl quaternized dimethylaminoethyl methacrylate, the ratio of (B):(C) is from about 45:55 to about 55:45, and the crosslinking agent is methylenebisacrylamide. An example of such a cationic polymer is one that is commercially available as a mineral oil dispersion (which can also include various dispersing aids such as PPG-1 trideceth-6) under the trademark Salcare~ SC92 from Allied Colloids Ltd.
(Norfolk, Virginia). This polymer has the proposed CTFA designation, "Polyquaternium 32 (and) Mineral Oil".
Other cationic polymers useful herein, are those not containing acrylamide or other (C) monomers, that is, n is zero. In these polymers the (A) and (B) monomer components are as described above. An especially preferred group of these non-acrylamide containing polymers is one in which 1 is also zero. In this instance the polymer is essentially a homopolymer of a , dialkylaminoalkyl methacrlyate monomer or its quaternary ammonium or acid addition salt. These diaklylaminoalkyl methacrylate polymers preferably contain a crosslinking agent as described above.
A cationic polymer, which is essentially a homopolymer, useful herein is one conforming to the general structure (A)1(B)m(C)n wherein 1 is zero, (B) is methyl quaternized dimethylaminoethyl 1~V0 97128785 PCT/US9710!!70 methacrylate, n is zero, and the crossiinking agent is methylenebisacrylamide.
An example of such a homopoiymer is commercially available as a mixture containing approximately 50% of the polymer, approximately 44°,% mineral oil, and approximately 6% PPG-1 trideceth-6 as a dispersing aid, from - Allied Colloids Ltd, (Norfolk, VA) under the trademark Saicare~ SC9S. This polymer has recently been given the CTFA designation "Polyquaternium 37 (and) Mineral Oil {and) PPG-I Trideceth-6".
PolvacrvIamide Polymers Also useful herein are polyacrylamide polymers, especially non-ionic polyacrylamide polymers including substituted branched or unbranched polymers.
These polymers can be formed from a variety of monomers including acrylamide and methacrylamide which are unsubstituted or subtituted with one or two alkyl groups (preferably C l to CS). Preferred are acrylate amide and methacrylate amide monomers in which the amide nitrogen is unsubstituted, or substituted with one or two CI to CS alkyl groups (preferably methyl, ethyl, or propyl), for example, acrylamide, methacrylamide, N-methacrytamide, N-methylinethacrylamide, N,N-dimethylmethacrylamide, N-isopropylacrylamide, N-isopropylmethacrylamide, and N,N-dimethylacrylamide.
These polymers have a molecular weight greater than about 1,000,000 preferably greater than about I,S000,000 and range up to about 30,000,000. Most preferred among these polyacrylamide polymers is the non-ionic polymer given the CTFA designation polyacrylamide and isoparaffm and Iaureth-7, available under the Tradename Sepigel 305 from Seppic Corporation (Fairfield, NJ).
Other polyacrylamide polymers useful herein include multi-block copolymers of acrylamides and substituted acrylamides with acrylic acids and substituted acrylic acids.
Commercially available examples of these mufti-block copolymers include Hypan SR1SOH, SSSOOV, SSSOOW, SSSAl00H, from Lipo Chemicals, Inc., {Patterson, NJ).
Polysaccharides A wide variety of polysaccharides are useful herein. By "polysaccharides" are meant gelling agents containing a backbone of repeating sugar (i.e.
carbohydrate) units. Nonlimiting examples of polysaccharide gelling agents include those selected from the group consisting of cellulose, carboxymethyl hydroxyethylcellulose, cellulose acetate propionate carboxylate, hydroxyethylcellulose, hydroxyethyl ethylcellulose, hydroxypropylcellulose, hydroxypropyl methyiceliulose, methyl hydroxyethylcellulose, microcrystalline cellulose, sodium cellulose sulfate, and'-mtactures thereof. Also useful herein are the alkyl substituted celluloses. In these polymers, the hydroxy groups of the cellulose polymer is hydroyxalkylated (preferably hydroxyethylated or hydroxypropyiated) to form a hydroxyalkylated cellulose which is then further modified with a C 10-C30 straight chain or branched chain alkyl group through an ether linkage.
Typically these polymers are ethers of C 10-C30 straight or branched chain alcohols with hydroxyalkylcelluloses. Examples of alkyl groups useful herein include those selected from the group consisting of stearyI, isostearyl, .~ lauryl, myristyi, cetyl, isocetyl, cocoyl (i.e. alkyl groups derived from the alcohols of coconut oil), palmityl, oleyl, linoleyi, linoienyl, ricinoleyl, behenyi, and mixtures thereof.

WO 97/28785 '~ ~ ~ ~ PCTJUS97/01I70 Preferred among the alkyl hydroxyalkyl cellulose ethe;s is the material given the CTFA designation cetyl hydroxyethyleellulose, which is the ether of cetyl alcohol and hydroxyethylcellulose. This material is sold under the tradename Natrosol~ CS Plus from Aqualon Corporation.
Other useful polysaccharides include scleroglucans comprising a linear chain of ( I->3) linked glucose units with a (1->6) linked glucose every three units, a.commercially available example of which is Clearogei~ CSl l from Michel Merrier Products Inc. (Mountainside, NJ).
ums Other additional thickening and gelling agents useful herein include materials which are primarily derived from natural sources. Nonlimiting examples of these gelling agent gums include materials selected from the group consisting of acacia, agar, algin, alginic acid, ammonium alginate, amylopectin, calcium alginate, cakium carrageenan, carnitine, carrageenan, dextrin, gelatin, gellan gum, guar gum, guar hydroxypropyltrimonium chloride, hectorite, hyaluroinic acid, hydrated silica, hydroxypropyl chitosan, hydroxypropyl guar, karaya Bum, kelp, locust bean gum, natto gum, potassium alginate, potassium carrageenan, propylene glycol alginate, sclerotium gum, sodium carboyxmethyl dextran, sodium carrageenan, tragacanth gum, xanthsn gum, and mixtures thereof:
Crossf dd Vinvl Ether/Maleic Anhydride Cooolvmers Other additional thickening and gelling agents useful hen:in include crosslinked copolymers of alkyl vinyl ethers and malefic anhdride. In these copolymers the vinyl ethers are represented by the formula ~R-O-CH~CH2 wherein R is a C 1 C6 alkyl group, preferably R is methyl. Prefemd crosslinking agents are C4-C20 dimes, preferably C6 to C16 dienes, and most preferably C8 to C12 dienes. A particularly prefen~ed copolymer is one formed from methyl vinyl ether and malefic anhydride wherein the copolymer has been crosslinked with decadiene, and wherein the polymer when diluted as a 0.5% aqueous solution at pH 7 at 25°C
has a viscosity of 50,000-70,000 cps when measured using a Brookfieid RTY
viscometer, spindle #7 at 10 rpm. This copolymer hss the CTFA designation PVM/MA decadiene crosspolymer and is commercially availsbk as Stabikze~ 06 from Ittteroationa! Specialty Products (Wayne NJ).
Crosslinked nolv(N-vinvhvrrolidones) Crosslinked polyvinyl(N-pyrrolidones) useful herein as additional thickening and gelling agents and include those described in U.S.
Patent No. 5,139,770, to Ship et al, issued August 18, 1992, and U.S. Patent No. 5,073,614, to Shih et al., issued December 17, 19911. - _ 'These gelling agates iypieally coa~ia from about 0.25'Y. to about IY. by weight of a crosslinking agent selected from the group consisting of divinyl ethers and diatlyl ethers of terminal diols containing from about 2 to about 12 carbon atoms, divinyl ethers and diallyl ethers of polyethylene glycols containing from about 2 to about 600 units, dienes having from about G to about 20 carbon atoms, divinyl benzene, vinyl and allyl ethers of pentarrytbritol, and the like. Typically, these gelling agents have a viscosity ' from about 25,000 cps to about 40,000 cps when measured as a 5% aqueous solution at 25°C using a Brookfield RVT viscometer with Spindle #6 at l0 rpm. Commercially available examples of these polymers include ACP-1120, ACP-1179, and ACP-1180, available from International Specialty Products (Wayne, NJ).

~ .~.p , ~;I .I

, . ' r _ WO 97IZ8785 ) \) PCTIUS97IOI170 Water The compositions of the present invention comprise from about 2.5% to about 99.1%, more preferably from about 50% to about 95%, and most preferably from about 60% to about 90% water.
The exact.amount of water in the formulation will vary with the ranges of the required and optional componenu chosen.
Optional Comnonena The compositions of the present invention can comprise a wide range of additional components. These additional components should be pharnnaceutically acceptable. The CTFA
genetic Ingredient Handbook. Second Edition, 1992 describes a wide variety of nonlimiting cosmetic and pharmaceutical ingredients commonly used in the skin care industry, which are suitable for use in the compositions of the present idvention. Noniimiting examples of functional classes of ingredients are described at page 537 of this reference. Examples of these functional classes include:
abrasives, absorbents, anti-acne agents, anticaking agents, antifosming agents, antimicrobisl agents, antioxidants, binders, biological additives, buffering agents, bulking agents, cbelating agents, chemical additives, colorants, cosmetic astringents, co~etic biocides, denaturants, drug astringents, external analgesics, film formecs, fragrance components, humectants, opacifying agents, pH adjusters, preservatives, propellants, reducing agents, skin bleaching agents, skin-conditioning agents (humtctants, miscellaneous, and occlusive).
Some nonlimiting examples of these additional components cited in the CTFA
Cosmetic Ingredient Handb~, as well as other materials useful herein, inchrde the following: vitamins and derivatives thereof (e.g. tocopherol, tocopberol acetate, retinoic acid, retinol; retinoids, and the like);
polymers for aidiag the film-forming properties and substantivity of the composition (such as a copolymer of eicaseae and vinyl pyrrolidone, an example of which is available from GAF Chemical Corporation as Ganex~ V-220); preservatives for maintaining the antitrticrobial integrity of the compositions; other anti-acne medicaments (e.g., resorcinol, sulfur, salicylic acid, erythromycin, zinc, and the like); skin bleaching (or lightening) agents including but not limited to hydroquinone, kojic acid; antioxidants; chelators and sequestrams; shin treatung agents such as alpha-hydroxy acids such as laeiic acid and glycolic acid, and aesthetic components such as fragrances, pigments, colorings, essential oils, skin sensates, asttingeats, skin soothing agents, skin healing agents and the like, nonlimiting examples of these aesthetic components include parttttenol and derivatives (e.g.
ethyl panthenol), aloe vera, pantothenic acid and its derivatives, clove oil, menthol, camphor, eucalyptus oil, eugenol, menthyl lactate, witch haul distillate, allantoin, bisabolol, dipotassium glycycrhizinate and the like; and skin conditioning agents such as the pmpoxylated glycecols described in U.S. Patent No. 4,976,953, to Orr et at., issued December 11, 1990'r Methods For Protecting The Skin From W Radiation The compositions of the present invention are useful for providing protection to human skin from the harmful effects of UV radiation. To protect the skin a safe and effective amount of the composition is applied to the skin. By "safe and effective amount" is meant an amount effective for providing the benefits of the present invention, i.e. protection from the harmful effects of UV
radiation, without any undue toxicity, allergic, or other unwanted side effects. By "protection" is meant that these compositions attenuate or reduce the amount of UV radiation reaching the skin's surface. Quantities of composition which are typically applied to provide protection are about, but not limited to, about 2 mg/cm2.
EXAMPLES
The following examples further describe and demonstrate embodiments within the scope of the present invention. The examples are given solely for the purpose of illustration and are not to be construed as limitations of the present invention, as many variations thereof are possible without departing from the spirit and scope of the invention.
Ingredients are identified by chemical or CTFA name.
EXAMPLES I-II
Phntnnrntr~rrtiyn l'nrr,e,nc;t;n.,o ineredient I II

WT.% WT.%

Octyl methoxycinnamate 6.0 6.0 Zinc Oxide 5.0 S.0 Isohexadecane 4.0 4.0 Glycerin 3.0 6.0 Polyquaternium 37 (and) mineral2.0 0.0 oil (and) PPG-I-trideceth-6I

Polyacrylamide (and) CI3-14 0.0 2.25 isoparaffm (and laureth-72 Dimethicone (and) dimethiconol30.0 I.0 Cetyl palmitate 0.0 I.0 Isopropyl palmitate 0.0 I.0 Cyclomethicone (and) dimethiconol40.5 0.0 Steareth-21 0.9 0.45 Stearyl alcohol 0.8 I.5 , Cetyl alcohol O.g l.g ' Cyclomethicone (and) dimethicone0.5 I 0.0 copolyols I

I',,; l~I i1 I

~ ~ ~
' wo 9~ris~as ) . -~.1 rcr~trs9~rolmo . .

' Benzyl alcohol 0.5 0.5 Methyl paraben 0.25 0.25 Vitamin E acetate 0:? 0.5 Propylparaben 0.15 0.1~

Disodium EDTA 0.13 0.13 DEA Oleth-3 phosphate 0. I 0.1 Steareth-2 ~ 0.1 0.05 Water QS 100 QS 100 I Available as Salcare SC95 from Allied Colloids.
2 Available as Sepigel 30S ftom Seppic, Inc.
3 Available as Dow Corning Q2-1403 fluid from Dow Corning Corporation.
4 Available as Dow Corning Q2-1401 fluid from Dow Corning Corporation.
Available as Dow Corning Q2-3225C from Dow Corning Corporation.
The above compositions are prepared as follows:
The emulsion water phase is preparad by combining the glycerin, methylparaben, disodium EDTA, and water in a mixing vessel. Next, a zinc dispersion premix is prepared by combining the isohexadecane, octyl methoxycinnamate, and DEA oleth-3 phosphate in a separate vessel, and warming slightly to solubilize the DEA oleth-3 phosphate. The zinc oxide is then stirred into the mix of oils for about several minutes, and this zinc dispersion is then milled.
Next, the remaining oil phase ingredients (cetyl pahaitate, isopropyl palmitate, steareth-21, stearyl alcohol, cetyl alcohol, Dow Corning Q2-3225C, vitamin E acetate, pmpylparaben, and steareth-2) are mixed into the zinc dispersion.
Both the water phase and oil phase are then heated to 70 - 80°C, and the oil phase is slowly added to the water phase while the system is milled to form an emulsion. 'the emulsion is then cooled with stirring. When the system reaches about 60°C, the Salcare SC95, Sepigel 305, Dow Coming Q2-1401, and Dow Corning Q2-1403 are added, and the product is milled again to disperse the polymers and silicones (when presort). The system is then further cooled with stirring.
The benzyl alcohol is then added when the product reaches about 48°C, and the product is poured into appropriate containers at about 30°C.
These compositions are useful for' applying to human skin to provide protection from the harmful effects of UV radiation.
* Trademark

Claims (10)

WHAT IS CLAIMED IS:
1. A photoprotective composition comprising:

(a) from 0.1% to 30% of a sunscreen active selected from the group consisting of 2-ethylhexyl N,N-dimethyl-p-aminobenzoate, 2-ethylhexyl p-methoxycinnamate, octocrylene, octyl salicylate, homomenthyl salicylate, p-aminobenzoic acid, oxybenzone, 2-phenylbenzimidazole-5-sulfonic acid, DEA p-methoxycinnamate, 4,4'-methoxy-t-butyldibenzoylmethane, 4-isopropyl dibenzoylmethane, 3-(4-methylbenzylidene) camphor, 3-benzylidene camphor, 4-N,N-(2-ethylexyl)methylaminobenzoic acid ester with 4-(2-hydroxyethoxy)dibenzoylmethane, titanium dioxide, zinc oxide, iron oxide, and mixtures thereof;

(b) from 0.5% to 20 % of a hydrophobic, structuring agent selected from the group consisting of saturated C16 to C30 fatty alcohols, saturated C16 to C30 fatty alcohols containing from about 1 to 5 moles of ethylene oxide, saturated C16 to C30 diols, saturated C16 to C30 monoglycerol ethers, saturated C16 to C30 hydroxy fatty acids, and mixtures thereof, having a melting point of at least 40°C;

(c) from 0.2% to 10% of a hydrophilic surfactant selected from the group consisting of nonionic surfactants, anionic surfactants, cationic surfactants, zwitterionic surfactants, amphoteric surfactants, and mixtures thereof; and (d) from 0.1% to 5% of a thickening agent selected from the group consisting of carboxylic acid polymers, crosslinked polyacrylate polymers, polyacrylamide polymers, polysaccharides, gums, crosslinked vinyl ether/maleic anhydride copolymers, crosslinked poly(N-vinylpyrrolidones), and mixtures thereof, and (e) - from 25% to 99.1% water.
2. A composition according to claim 1 wherein said thickening agent is selected from the group consisting of carboxylic acid polymers, crosslinked polyacrylate polymers, polyacrylatnide polymers, and mixtures thereof; preferably wherein said thickening agent is selected from the group consisting of crosslinked polyacrylate polymers; polyacrylamide polymers, and mixtures thereof.
3. A composition according to Claim 2 wherein said crosslinked cationic polymer corresponds to the formula (A)l(B)m(C) wherein (A) is a dialkylaminoalkyl acrylate monomer or its quaternary ammonium or acid addition salt, (B) is a dialkylaminoskyl methacrylate monomer or its quaternary ammonium or acid addition salt, (C) is acrylamide, 1 is an integer of 0 or greater, m is an integer of 1 or great, and n is an integer of 0 or greater, wherein said polymer contains a crosslinking agent.
4. A composition according to Claim 3 wherein said crosslinking agent is selected from the group consisting of methylene bisacrylamide, ethylene glycol di-(meth)acrylate, di-(meth)acrylamide, cyanomethylacrylate, vinyloxyethyiacrylate, vinyloxyethylmethacrylate, allyl pentaerythritol, trimethylolpropane, diallylether, allyl sucrose, butadiene, isoprene, divinyl benzene, divinyl naphthalene, allyl acrylate, and mixtures thereof.
5. A composition according to Claim 4 wherein said crosslinked cationic polymer is selected from the group consisting of polyquaternium 32, polyquaternium 37, and mixtures thereof.
6. A composition according to Claim 2 wherein said polyacrylamide polymer has a molecular wait from 1,000,000 to 30,000,000.
7. A composition according to any of Claims 1- 6 wherein said sunscreen active is selected from the group consisting of 2-ethylhexyl p-methoxycinnamate, 4,4'-methoxy-t-butyldibenzoylmethane, zinc oxide, and mixtures thereof; and wherein said hydrophobic structuring agent is selected from the group consisting of stearyl alcohol, cetyl alcohol, behenyl alcohol, polyethylene glycol ether of stearyl alcohol having an average of about 2 ethylene oxide units, and mixtures thereof.
8. A composition according to Claim 7 wherein said hydrophilic surfactant is a nonionic surfactant.
9. A composition according to Claim 7 wherein said nonionic surfactant is selected from the group consisting of steareth-21, ceteareth-20, ceteareth-12, sucrose cocoate, steareth-100, PEG-100 stearate, and mixtures thereof.
10. A method for protecting human skin from the harmful effects of UV
radiation, said method comprising applying a safe and effective amount of the composition of any of Claims 1-9 to human skin.
CA002244887A 1996-02-09 1997-01-24 Photoprotective compositions Expired - Lifetime CA2244887C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/599,202 1996-02-09
US08/599,202 US5759524A (en) 1996-02-09 1996-02-09 Photoprotective compositions
PCT/US1997/001170 WO1997028785A1 (en) 1996-02-09 1997-01-24 Photoprotective compositions

Publications (2)

Publication Number Publication Date
CA2244887A1 CA2244887A1 (en) 1997-08-14
CA2244887C true CA2244887C (en) 2003-07-08

Family

ID=24398670

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002244887A Expired - Lifetime CA2244887C (en) 1996-02-09 1997-01-24 Photoprotective compositions

Country Status (11)

Country Link
US (2) US5759524A (en)
EP (1) EP0893986A1 (en)
JP (1) JP3414406B2 (en)
KR (1) KR100299498B1 (en)
CN (1) CN1158065C (en)
AU (1) AU725142B2 (en)
CA (1) CA2244887C (en)
CZ (1) CZ246798A3 (en)
IN (1) IN1997DE00284A (en)
MX (1) MX209739B (en)
WO (1) WO1997028785A1 (en)

Families Citing this family (128)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2736263B1 (en) * 1995-07-07 1997-09-26 C3D Sarl DEPIGMENTING DERMOCOSMETIC COMPOSITION AND ITS USE
US5759524A (en) * 1996-02-09 1998-06-02 The Procter & Gamble Company Photoprotective compositions
FR2780884B1 (en) 1998-07-08 2002-07-19 Oreal METHOD FOR PHOTOSTABILIZATION OF SOLAR FILTERS DERIVED FROM DIBENZOYLMETHANE, PHOTOSTABILIZED COSMETIC FILTERING COMPOSITIONS THUS OBTAINED AND THEIR USES
FR2780879B1 (en) * 1998-07-09 2002-09-20 Oreal PHOTOPROTECTOR COSMETIC COMPOSITION CONTAINING AN ANIONIC SURFACTANT, COMPOUND FILTERING ULTRAVIOLET RADIATION AND CATIONIC OR ZPHITTERIONIC AMPHIPHILIC COMPOUND AND USE THEREOF
AU6273299A (en) * 1998-09-30 2000-04-17 Avon Products Inc. Compositions having a sunscreen for use in personal cleansing products
CA2349698A1 (en) * 1998-11-03 2000-05-11 Bristol-Myers Squibb Company Skin moisturizer compositions containing a sebum control agent
US6297337B1 (en) * 1999-05-19 2001-10-02 Pmd Holdings Corp. Bioadhesive polymer compositions
US7008963B2 (en) * 1999-07-03 2006-03-07 The William M. Yarbrough Foundation Urushiol induced contact dermatitis solution
CA2387703A1 (en) 1999-10-01 2001-04-12 Johnson & Johnson Consumer Companies, Inc. Method for calming human beings using personal care compositions
JP2001342110A (en) * 2000-06-02 2001-12-11 Ezaki Glico Co Ltd Skin care preparation
US8512718B2 (en) 2000-07-03 2013-08-20 Foamix Ltd. Pharmaceutical composition for topical application
DE10040969A1 (en) * 2000-08-22 2002-03-07 Ifac Inst Fuer Angewandte Coll Use of L-ascorbic acid in cosmetic emulsions
DE10059239A1 (en) * 2000-11-29 2002-06-06 Cognis Deutschland Gmbh Cosmetic and / or pharmaceutical emulsions
FR2819414A1 (en) * 2001-01-15 2002-07-19 Cognis France Sa COSMETIC AND / OR PHARMACEUTICAL PREPARATIONS COMPRISING EXTRACTS FROM PLANTS RESOURCING
US6444195B1 (en) 2001-06-18 2002-09-03 Johnson & Johnson Consumer Companies, Inc. Sunscreen compositions containing a dibenzoylmethane derivative
DE10148827B4 (en) * 2001-10-04 2004-12-09 Beiersdorf Ag O / W emulsions containing ascorbic acid, cosmetic and / or dermatological preparations containing them, their use and processes for their preparation
US7025952B1 (en) 2005-01-31 2006-04-11 Aquea Scientific Corporation Methods of preparation and use of bodywashes containing additives
US20060173709A1 (en) * 2005-01-31 2006-08-03 Traynor Daniel H Bodywash additive business methods
US7037513B1 (en) 2005-01-31 2006-05-02 Aquea Scientific Corporation Bodywash additives
US6998113B1 (en) * 2005-01-31 2006-02-14 Aquea Scientific Corporation Bodywashes containing additives
DE10155962A1 (en) * 2001-11-09 2003-05-22 Beiersdorf Ag Cosmetic and dermatological light protection formulations containing hydroxybenzophenones and acrylamide polymers
FR2832630B1 (en) * 2001-11-28 2005-01-14 Oreal COSMETIC AND / OR DERMATOLOGICAL COMPOSITION CONTAINING AT LEAST ONE OXIDATION-SENSITIVE HYDROPHILIC ACTIVE STABILIZED WITH AT LEAST ONE COPOLYMER OF N-VINYLIMIDAZOLE
GB2411478A (en) 2002-01-29 2005-08-31 Johnson & Johnson Consumer Method of measuring the stress or relaxation level of a mammal
US20040086474A1 (en) * 2002-06-17 2004-05-06 The Procter & Gamble Company Multi-step cosmetic benefit foundation kit and associated methods
EP1374849B1 (en) * 2002-06-20 2005-11-23 L'oreal Cosmetic and/or dermatological use of a composition containing at least one oxidation-sensitive hydrophilic active stabilised by at least one polymer or copolymer of maleic anhydride
FR2845002B1 (en) * 2002-09-30 2004-11-05 Oreal COSMETIC OR DERMATOLOGICAL COMPOSITION CONTAINING AN ASCORBIC ACID DERIVATIVE AND A FILTER
US20040096406A1 (en) * 2002-09-30 2004-05-20 L'oreal Composition containing ascorbic acid compound and screening agent, method of use
IL152486A0 (en) 2002-10-25 2003-05-29 Meir Eini Alcohol-free cosmetic and pharmaceutical foam carrier
US20070292355A1 (en) * 2002-10-25 2007-12-20 Foamix Ltd. Anti-infection augmentation foamable compositions and kit and uses thereof
US20060193789A1 (en) * 2002-10-25 2006-08-31 Foamix Ltd. Film forming foamable composition
US7820145B2 (en) 2003-08-04 2010-10-26 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US9265725B2 (en) 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
KR101108439B1 (en) * 2002-10-25 2012-01-31 포믹스 리미티드 Cosmetic and pharmaceutical foam
US10117812B2 (en) 2002-10-25 2018-11-06 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US7704518B2 (en) 2003-08-04 2010-04-27 Foamix, Ltd. Foamable vehicle and pharmaceutical compositions thereof
US9211259B2 (en) * 2002-11-29 2015-12-15 Foamix Pharmaceuticals Ltd. Antibiotic kit and composition and uses thereof
US8119109B2 (en) 2002-10-25 2012-02-21 Foamix Ltd. Foamable compositions, kits and methods for hyperhidrosis
US8119150B2 (en) 2002-10-25 2012-02-21 Foamix Ltd. Non-flammable insecticide composition and uses thereof
US9668972B2 (en) 2002-10-25 2017-06-06 Foamix Pharmaceuticals Ltd. Nonsteroidal immunomodulating kit and composition and uses thereof
US20050186142A1 (en) * 2002-10-25 2005-08-25 Foamix Ltd. Kit and composition of imidazole with enhanced bioavailability
US20050271596A1 (en) * 2002-10-25 2005-12-08 Foamix Ltd. Vasoactive kit and composition and uses thereof
US20080138296A1 (en) 2002-10-25 2008-06-12 Foamix Ltd. Foam prepared from nanoemulsions and uses
US8900554B2 (en) 2002-10-25 2014-12-02 Foamix Pharmaceuticals Ltd. Foamable composition and uses thereof
US7700076B2 (en) * 2002-10-25 2010-04-20 Foamix, Ltd. Penetrating pharmaceutical foam
US8486376B2 (en) * 2002-10-25 2013-07-16 Foamix Ltd. Moisturizing foam containing lanolin
US6566473B1 (en) * 2002-11-20 2003-05-20 Isp Investments Inc. Process for making a vinyl amide polymer composition for skin and hair compositions
US20040126339A1 (en) * 2002-12-31 2004-07-01 Roszell James A. Sunscreen composition and methods for manufacturing and using a sunscreen composition
US7575739B2 (en) * 2003-04-28 2009-08-18 Foamix Ltd. Foamable iodine composition
CA2526536C (en) * 2003-05-29 2010-10-12 Sun Pharmaceuticals Corporation Sunscreen composition
US8795693B2 (en) 2003-08-04 2014-08-05 Foamix Ltd. Compositions with modulating agents
AU2004261063A1 (en) * 2003-08-04 2005-02-10 Foamix Ltd. Foam carrier containing amphiphilic copolymeric gelling agent
US8486374B2 (en) * 2003-08-04 2013-07-16 Foamix Ltd. Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses
US20080069779A1 (en) * 2003-08-04 2008-03-20 Foamix Ltd. Foamable vehicle and vitamin and flavonoid pharmaceutical compositions thereof
US20050075407A1 (en) * 2003-08-25 2005-04-07 Foamix Ltd. Foam incorporating eutetic mixture
KR20060109886A (en) * 2003-11-06 2006-10-23 유니레버 엔.브이. Improved cosmetic composition comprising vitamin b3, vitamin b6 and an organic acid
US7695726B2 (en) * 2004-01-23 2010-04-13 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Pigmented cosmetic composition exhibiting radiance with soft focus
US7202199B2 (en) * 2004-03-31 2007-04-10 Unilever Home & Personal Care Usa Division Of Conopco, Inc. Isotropic cleansing composition with particulate optical modifiers
US6906015B1 (en) * 2004-03-31 2005-06-14 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Ordered liquid crystalline cleansing composition with particulate optical modifiers
GB2412866A (en) * 2004-04-02 2005-10-12 Ciba Sc Holding Ag Amino-benzophenone UV filter formulations for the prevention of tanning
US20050249684A1 (en) * 2004-05-07 2005-11-10 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Taurate formulated pigmented cosmetic composition exhibiting radiance with soft focus
EP1811949A1 (en) * 2004-05-31 2007-08-01 Showa Denko Kabushiki Kaisha Topical slimming preparation and a cosmetic containing a carnitine derivative
US20050276765A1 (en) * 2004-06-10 2005-12-15 Paul Nghiem Preventing skin damage
ATE536168T1 (en) * 2004-09-01 2011-12-15 Basf Se MICROPARTICULAR ORGANIC UV ABSORBING COMPOSITION
MX2007004280A (en) * 2004-10-15 2007-05-16 Bayer Consumer Care Ag Acidic and buffered skin-care compositions comprising nicotinamid and an absorbing agent.
US20060286046A1 (en) * 2005-01-05 2006-12-21 Haber C Andrew Skin care compositions
US7001592B1 (en) 2005-01-31 2006-02-21 Aquea Scientific Corporation Sunscreen compositions and methods of use
WO2006089692A1 (en) * 2005-02-28 2006-08-31 Unilever Plc Improved cosmetic composition
US20080112904A1 (en) * 2005-03-08 2008-05-15 Daniel Henry Traynor Sunscreen Compositions And Methods Of Use
EA015357B1 (en) * 2005-03-23 2011-06-30 Мэри Кэй Инк. Skin lightening compositions
CN101365413A (en) * 2006-01-05 2009-02-11 西姆莱斯有限责任两合公司 Formulations of low oil content comprising diphenylmethane derivatives
DE102006005768A1 (en) * 2006-02-07 2007-08-09 Henkel Kgaa Rheopex gels as carrier medium
US20070183995A1 (en) * 2006-02-09 2007-08-09 Conopco, Inc., D/B/A Unilever Compounds useful as agonists of A2A adenosine receptors, cosmetic compositions with A2A agonists and a method for using the same
US20070189989A1 (en) * 2006-02-16 2007-08-16 Cantwell Maggie Y Cosmetic compositions and methods of making and using the compositions
EP2023889A2 (en) * 2006-05-31 2009-02-18 Neutrogena Corporation Clear sunscreen compositions
US9565919B2 (en) 2006-09-08 2017-02-14 The Procter & Gamble Company Antiperspirant compositions and methods for making same
US8187578B2 (en) * 2006-09-08 2012-05-29 The Procter & Gamble Company Antiperspirant compositions and methods for making same
US20080260655A1 (en) * 2006-11-14 2008-10-23 Dov Tamarkin Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
EP2073794A2 (en) * 2006-11-14 2009-07-01 Foamix Ltd. Stable non-alcoholic foamable pharmaceutical emulsion compositions with an unctuous emollient and their uses
DE102007001019A1 (en) * 2007-01-02 2008-07-03 Henkel Kgaa Cosmetic compositions useful for care and conditioning of keratinic fibers, especially hair, comprise a mineral powder and a cationic, amphoteric or zwitterionic polymer
US20080292560A1 (en) * 2007-01-12 2008-11-27 Dov Tamarkin Silicone in glycol pharmaceutical and cosmetic compositions with accommodating agent
WO2008143761A1 (en) * 2007-05-14 2008-11-27 Sytheon Ltd. Sunscreen compositions and methods
CN101730518A (en) * 2007-05-21 2010-06-09 阿奎耶科技公司 Highly charged microcapsule
US8636982B2 (en) 2007-08-07 2014-01-28 Foamix Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
US20090130029A1 (en) * 2007-11-21 2009-05-21 Foamix Ltd. Glycerol ethers vehicle and pharmaceutical compositions thereof
US9439857B2 (en) 2007-11-30 2016-09-13 Foamix Pharmaceuticals Ltd. Foam containing benzoyl peroxide
WO2010041141A2 (en) 2008-10-07 2010-04-15 Foamix Ltd. Oil-based foamable carriers and formulations
WO2009072007A2 (en) * 2007-12-07 2009-06-11 Foamix Ltd. Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof
CA2712120A1 (en) * 2008-01-14 2009-07-23 Foamix Ltd. Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses
US7842725B2 (en) 2008-07-24 2010-11-30 Ecolab USA, Inc. Foaming alcohol compositions with selected dimethicone surfactants
WO2010125470A2 (en) 2009-04-28 2010-11-04 Foamix Ltd. Foamable vehicle and pharmaceutical compositions comprising aprotic polar solvents and uses thereof
WO2011013009A2 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
WO2011013008A2 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
US9849142B2 (en) 2009-10-02 2017-12-26 Foamix Pharmaceuticals Ltd. Methods for accelerated return of skin integrity and for the treatment of impetigo
WO2011064631A1 (en) 2009-10-02 2011-06-03 Foamix Ltd. Surfactant-free, water-free, foamable compositions and breakable foams and their uses
US8173108B2 (en) * 2009-11-04 2012-05-08 Conopco, Inc. Sunscreen composition
US8206691B2 (en) * 2009-11-04 2012-06-26 Conopco, Inc. Sunscreen composition with fatty acid alkanolamides
US20110104082A1 (en) * 2009-11-04 2011-05-05 Conopco, Inc., D/B/A Unilever Enhanced photo protection
JP5728388B2 (en) * 2009-11-06 2015-06-03 花王株式会社 Oil-in-water emulsified cosmetic
US8174881B2 (en) 2009-11-24 2012-05-08 Micron Technology, Inc. Techniques for reducing disturbance in a semiconductor device
WO2011137563A1 (en) 2010-05-07 2011-11-10 Unilever Plc High solvent content emulsions
DE102010022061A1 (en) 2010-05-31 2011-12-01 Beiersdorf Ag Polymer combinations for cosmetic preparations
US20120122936A1 (en) 2010-11-11 2012-05-17 Conopco, Inc., D/B/A Unilever Leave-on nonsolid skin conditioning compositions containing 12-[(12-hydroxyoctadecanoyl)oxy] octadecanoic acid
JP5866372B2 (en) 2010-11-11 2016-02-17 ユニリーバー・ナームローゼ・ベンノートシヤープ Leave-on non-solid skin conditioning composition containing 12-hydroxystearic acid
US8613939B2 (en) 2010-12-15 2013-12-24 Conopco, Inc. Leave-on nonsolid skin conditioning compositions containing 12-hydroxystearic acid and ethoxylated hydrogenated castor oil
US20120214871A1 (en) 2011-02-17 2012-08-23 Conopco, Inc., D/B/A Unilever Leave-on nonsolid oil-continuous skin conditioning compositions containing 12-hydroxystearic acid
CA2834035C (en) 2011-04-27 2018-12-18 Isp Investments Inc. Clear wet sprays and gels
US11724134B2 (en) 2012-11-06 2023-08-15 CoLabs International Corporation Compositions containing a cellulose derived capsule with a sunscreen active agent
EP2916814B1 (en) 2012-11-06 2020-02-12 Colabs International Corporation Composition containing a cellulose derived capsule with a sunscreen
US11707421B2 (en) 2012-11-06 2023-07-25 Colabs Int'l Corp. Compositions containing a flexible derived capsule with an active agent
US10322301B2 (en) 2012-11-06 2019-06-18 CoLabs International Corporation Compositions containing a cellulose derived capsule with a sunscreen active agent
US11491088B2 (en) 2012-11-06 2022-11-08 CoLabs International Corporation Compositions containing a capsule with a moisturizing agent
US11690793B2 (en) 2012-11-06 2023-07-04 Colabs Int'l Corp. Composition containing a cellulose derived capsule with a sunscreen
CN102940590A (en) * 2012-11-22 2013-02-27 金红叶纸业集团有限公司 Skin care composition and tissue using same
US9351922B2 (en) 2012-12-12 2016-05-31 Thomas Christopher Balshi Composition for correcting skin pigment conditions
EP2934458B2 (en) 2012-12-20 2023-02-22 Unilever Global IP Limited Eutectic mixtures in personal care compositions
CN103142419A (en) * 2013-02-26 2013-06-12 金红叶纸业集团有限公司 Skin care composition and facial tissue employing same
EP2969021B1 (en) 2013-03-15 2019-08-07 ISP Investments LLC Hair care compositions comprising polyelectrolyte complexes for durable benefits
US9439841B2 (en) 2013-06-06 2016-09-13 Ecolab Usa Inc. Alcohol based sanitizer with improved dermal compatibility and feel
CN103405349A (en) * 2013-08-14 2013-11-27 金红叶纸业集团有限公司 Skin care composition and paper towel using same
JP5913411B2 (en) 2014-03-26 2016-04-27 株式会社 資生堂 Oil-in-water emulsified cosmetic
EP3331491B1 (en) 2015-08-04 2022-03-23 ISP Investments LLC Polymers derived from amino-functional vinyl alcohol ethers and applications thereof
KR102453888B1 (en) * 2015-09-30 2022-10-11 (주)아모레퍼시픽 Shapable composition for hair care
MX2020012139A (en) 2016-09-08 2021-01-29 Vyne Pharmaceuticals Inc Compositions and methods for treating rosacea and acne.
AU2019291885A1 (en) 2018-06-27 2021-02-04 CoLabs International Corporation Compositions comprising silicon dioxide-based particles including one or more agents
US11458090B2 (en) * 2019-05-02 2022-10-04 L'oreal SPF-enhanced water-releasing sunscreen composition
WO2020230617A1 (en) * 2019-05-10 2020-11-19 三洋化成工業株式会社 Cosmetic composition
JP2022539864A (en) 2019-07-11 2022-09-13 ビーエーエスエフ ソシエタス・ヨーロピア Cosmetic composition of liquid crystalline lipid particles for hair care composition
CN110746892B (en) * 2019-11-13 2021-09-24 合肥乐凯科技产业有限公司 Surfactant for protective film and preparation method thereof

Family Cites Families (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2798053A (en) * 1952-09-03 1957-07-02 Goodrich Co B F Carboxylic polymers
FR2096712A1 (en) * 1970-06-29 1972-02-25 Giraux Georges Steroid/b group vitamin compsns - for prevention and treatment of skin-photosensitivity disorders
DE2136697A1 (en) * 1971-07-22 1973-02-15 Penaten Pharm Fabrik Dr Med Ri Antiphlogistic-contg cosmetic preparations - for preventing sunburn and/or improving tanning
US3937810A (en) * 1972-01-09 1976-02-10 Lever Brothers Company A skin lightening composition and method of using the same
GB1370236A (en) * 1972-01-11 1974-10-16 Unilever Ltd Skin composition
DE2242553A1 (en) * 1972-08-30 1974-03-07 Koehler Valentin Cosmetic compsns contg folic acid or its salts - exerting antiseborrhoic effect and suppressing skin ageing
IN144276B (en) * 1975-02-18 1978-04-22 Lever Hindustan Ltd
GB1533119A (en) * 1975-04-10 1978-11-22 Unilever Ltd Skin lightening compositions
CH632668A5 (en) * 1977-12-09 1982-10-29 Hoffmann La Roche COSMETIC AGENT.
US4877805A (en) * 1985-07-26 1989-10-31 Kligman Albert M Methods for treatment of sundamaged human skin with retinoids
GB8302683D0 (en) * 1983-02-01 1983-03-02 Unilever Plc Skin treatment composition
US4509949A (en) * 1983-06-13 1985-04-09 The B. F. Goodrich Company Water thickening agents consisting of copolymers of crosslinked acrylic acids and esters
US4888342A (en) * 1984-05-16 1989-12-19 Kligman Albert M Methods for treatment of sundamaged human skin with retinoids
JPS6137712A (en) * 1984-07-31 1986-02-22 Keita Inoue Cosmetic
US4663157A (en) * 1985-02-28 1987-05-05 The Proctor & Gamble Company Sunscreen compositions
US4732930A (en) * 1985-05-20 1988-03-22 Massachusetts Institute Of Technology Reversible, discontinuous volume changes of ionized isopropylacrylamide cells
US4822604A (en) * 1985-05-20 1989-04-18 S. C. Johnson & Son, Inc. Local treatment of dandruff, seborrheic dermatitis, and psoriasis
FR2608424B1 (en) * 1986-12-17 1989-06-16 Cazacou Cecilia TANNING ACCELERATOR WITHOUT SUNSCREEN USING A MELANOGENESIS-PROMOTING NATURAL COMPLEX
US5389677B1 (en) * 1986-12-23 1997-07-15 Tristrata Inc Method of treating wrinkles using glycalic acid
US5091171B2 (en) * 1986-12-23 1997-07-15 Tristrata Inc Amphoteric compositions and polymeric forms of alpha hydroxyacids and their therapeutic use
US5385938B1 (en) * 1986-12-23 1997-07-15 Tristrata Inc Method of using glycolic acid for treating wrinkles
US4960764A (en) * 1987-03-06 1990-10-02 Richardson-Vicks Inc. Oil-in-water-in-silicone emulsion compositions
JP2506384B2 (en) * 1987-09-25 1996-06-12 三省製薬株式会社 Topical
US4906459A (en) * 1987-10-23 1990-03-06 The Procter & Gamble Company Hair care compositions
NZ227994A (en) * 1988-02-16 1990-09-26 Richardson Vicks Inc Skin conditioning composition comprising glycerin and a silicone fluid phase
WO1989010738A1 (en) * 1988-05-09 1989-11-16 Solarcare, Inc. Sunscreen composition and applicator system
EP0347145A3 (en) * 1988-06-14 1990-10-24 University Of Utah Research Foundation Heterogeneous interpenetrating polymer networks for the controlled release of drugs
IN169917B (en) * 1989-03-21 1992-01-11 Lever Hindustan Ltd
GB8909095D0 (en) * 1989-04-21 1989-06-07 Allied Colloids Ltd Thickened aqueous compositions
GB8910366D0 (en) * 1989-05-05 1989-06-21 Unilever Plc Skin composition
JP2881333B2 (en) * 1990-05-22 1999-04-12 サンスター株式会社 Whitening cosmetics
DE4018964C1 (en) * 1990-06-13 1991-07-04 Gerhard Prof. Dr.Med. 8602 Muehlhausen De Weber
WO1992013566A1 (en) * 1991-01-31 1992-08-20 Massachusetts Institute Of Technology Interpenetrating-polymer network phase-transition gels
US5229104A (en) * 1991-04-29 1993-07-20 Richardson-Vicks Inc. Artificial tanning compositions containing positively charged paucilamellar vesicles
GB9109733D0 (en) * 1991-05-07 1991-06-26 Unilever Plc Cosmetic composition
FR2676649B1 (en) * 1991-05-22 1994-02-25 Lvmh Recherche COSMETIC OR PHARMACEUTICAL COMPOSITION, ESPECIALLY DERMATOLOGICAL, FOR PROMOTING PIGMENTATION OF THE SKIN OR HAIR, CONTAINING A CYPERUS EXTRACT AND METHOD FOR THE PRODUCTION THEREOF.
US5296500A (en) * 1991-08-30 1994-03-22 The Procter & Gamble Company Use of N-acetyl-cysteine and derivatives for regulating skin wrinkles and/or skin atrophy
JP3064553B2 (en) * 1991-09-18 2000-07-12 三省製薬株式会社 Kojic acid fructoside and external preparation for skin containing the same
EG20380A (en) * 1991-10-16 1999-02-28 Richardson Vicks Inc Enhanced skin penetration system for improved topical delivery of drugs
US5271930A (en) * 1991-11-20 1993-12-21 Finetex, Inc. Benzoate esters of polyalkoxylated block copolymers
FR2684300B1 (en) * 1991-11-29 1994-03-11 Lvmh Recherche COSMETIC OR PHARMACEUTICAL COMPOSITION, ESPECIALLY DERMATOLOGICAL, IN PARTICULAR FOR PROMOTING PIGMENTATION OF THE SKIN OR HAIR, CONTAINING A BALLOTE EXTRACT, AND ITS MANUFACTURING METHOD.
GB9211708D0 (en) * 1992-06-03 1992-07-15 Unilever Plc Cosmetic composition
DE4223463A1 (en) * 1992-07-16 1994-01-20 Bayer Ag Cosmetic care product against light-induced skin aging
WO1994002176A1 (en) * 1992-07-28 1994-02-03 The Procter & Gamble Company Pharmaceutical composition for topical use containing a crosslinked cationic polymer and an alkoxylated ether
JP3480953B2 (en) * 1992-08-17 2003-12-22 株式会社コーセー External preparation for skin
JPH06107531A (en) * 1992-09-28 1994-04-19 Kao Corp Cosmetic for fair skin and beauty
GB9223235D0 (en) * 1992-11-05 1992-12-16 Unilever Plc Cosmetic composition
US5411991A (en) * 1992-12-22 1995-05-02 Shander; Douglas Method of reducing hair growth employing sulfhydryl active compounds
CN1057669C (en) * 1993-01-11 2000-10-25 普罗克特和甘保尔公司 Cosmetic compositions containing surface treated pigments
US5476648A (en) * 1993-03-12 1995-12-19 Bernel Chemical Oil in water emulsions
US5498406A (en) * 1993-04-30 1996-03-12 Nearn; Malcolm R. Titanium dioxide-based sunscreen compositions
CN1079665C (en) * 1993-07-03 2002-02-27 普罗克特和甘保尔公司 Personal cleansing compositions
US5411741A (en) * 1993-07-29 1995-05-02 Zaias; Nardo Method and composition for skin depigmentation
DE4327679A1 (en) * 1993-08-13 1995-02-16 Lancaster Group Ag Functional oxygenated preparation
ES2153026T5 (en) * 1994-02-18 2004-05-16 Unilever N.V. COMPOSITIONS OF PERSONAL WASHING.
JPH07277939A (en) * 1994-04-05 1995-10-24 Dowa Mining Co Ltd Skin external preparation
US5520919A (en) * 1994-08-15 1996-05-28 Lerner; Sheldon Vitamin A palmitate composition and methodology for repairing and rejuvenating human skin
US5556887A (en) * 1994-08-15 1996-09-17 Lerner; Sheldon Improved a palmitate composition for topical application which achieves to the entire dermal membrane.
KR100294382B1 (en) * 1995-05-26 2001-10-19 알 브이 테이트 (로드니 비버스 테이트), 에이치 드로이. 씨. 지. 오닌크, 이. 에디, 산드라 웨드워즈 (에스 제이 에드워즈) Treatment Regime for Skin
JPH0912471A (en) * 1995-06-29 1997-01-14 Noevir Co Ltd Skin preparation for external use
US5759524A (en) * 1996-02-09 1998-06-02 The Procter & Gamble Company Photoprotective compositions

Also Published As

Publication number Publication date
JPH11504043A (en) 1999-04-06
IN1997DE00284A (en) 2015-07-31
KR19990082404A (en) 1999-11-25
KR100299498B1 (en) 2001-09-06
US5759524A (en) 1998-06-02
MX209739B (en) 2002-08-16
CN1213296A (en) 1999-04-07
AU1709397A (en) 1997-08-28
WO1997028785A1 (en) 1997-08-14
MX9806465A (en) 1999-01-31
CN1158065C (en) 2004-07-21
CZ246798A3 (en) 1998-11-11
EP0893986A1 (en) 1999-02-03
JP3414406B2 (en) 2003-06-09
US6024942A (en) 2000-02-15
CA2244887A1 (en) 1997-08-14
AU725142B2 (en) 2000-10-05

Similar Documents

Publication Publication Date Title
CA2244887C (en) Photoprotective compositions
US5585104A (en) Cleansing emulsions
US5534265A (en) Thickened nonabrasive personal cleansing compositions
CA2160107C (en) Compositions for imparting an artificial tan and protecting the skin from uv radiation
US5948416A (en) Stable topical compositions
CA2227967C (en) Topical compositions having improved skin feel
US5720961A (en) Skin cleansing compositions
US6153176A (en) Low pH sunscreen compositions
MXPA01007950A (en) Photostable UV protection compositions
AU7456696A (en) Stable photoprotective compositions
CA2459424A1 (en) Skin moisturizing composition
KR20010012848A (en) Compositions containing select solid polyol fatty acid polyesters
MXPA99010832A (en) Compositions containing select solid polyol fatty acid polyesters

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry

Effective date: 20170124